Yeo E J, Briggs W T, Wagner C
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
J Biol Chem. 1999 Dec 31;274(53):37559-64. doi: 10.1074/jbc.274.53.37559.
Glycine N-methyltransferase (EC 2.1.1.20) catalyzes the methylation of glycine by S-adenosylmethionine to form sarcosine and S-adenosylhomocysteine. The enzyme was previously shown to be abundant in both the liver and pancreas of the rat, to consist of four identical monomers, and to contain tightly bound folate polyglutamates in vivo. We now report that the inhibition of glycine N-methyltransferase by (6S)-5-CH(3)-H(4)PteGlu(5) is noncompetitive with regard to both S-adenosylmethionine and glycine. The enzyme exhibits strong positive cooperativity with respect to S-adenosylmethionine. Cooperativity increases with increasing concentrations of 5-CH(3)-H(4)PteGlu(5) and is greater at physiological pH than at pH 9.0, the pH optimum. Under the same conditions, cooperativity is much greater for the pancreatic form of the enzyme. The V(max) for the liver form of the enzyme is approximately twice that of the pancreatic enzyme, while K(m) values for each substrate are similar in the liver and pancreatic enzymes. For the liver enzyme, at pH 7.0 half-maximal inhibition is seen at a concentration of about 0.2 microM (6S)-5-CH(3)-H(4)PteGlu(5), while at pH 9.0 this value is increased to about 1 microM. For the liver form of the enzyme, 50% inhibition with respect to S-adenosylmethionine at pH 7.4 occurs at about 0.27 microM. The dissociation constant, K(s), obtained from binding data at pH 7.4 is 0.095. About 1 mol of (6S)-5-CH(3)-H(4)PteGlu(5) was bound per tetramer at pH 7.0, and 1.6 mol were bound at pH 9.0. The degree of binding and inhibition were closely parallel at each pH. At equal concentrations of (6R,6S)- and (6S)-5-CH(3)-H(4)PteGlu(5), the natural (6S) form was about twice as inhibitory. These studies indicate that glycine N-methyltransferase is a highly allosteric enzyme, which is consistent with its role as a regulator of methyl group metabolism in both the liver and the pancreas.
甘氨酸N-甲基转移酶(EC 2.1.1.20)催化甘氨酸与S-腺苷甲硫氨酸发生甲基化反应,生成肌氨酸和S-腺苷高半胱氨酸。此前研究表明,该酶在大鼠肝脏和胰腺中含量丰富,由四个相同的单体组成,且在体内含有紧密结合的叶酸多聚谷氨酸。我们现在报告,(6S)-5-CH(3)-H(4)PteGlu(5)对甘氨酸N-甲基转移酶的抑制作用,对于S-腺苷甲硫氨酸和甘氨酸而言均为非竞争性抑制。该酶对S-腺苷甲硫氨酸表现出强烈的正协同性。协同性随5-CH(3)-H(4)PteGlu(5)浓度的增加而增强,在生理pH值下比在最适pH值9.0时更大。在相同条件下,该酶胰腺形式的协同性更强。肝脏形式的该酶的V(max)约为胰腺酶的两倍,而每种底物的K(m)值在肝脏酶和胰腺酶中相似。对于肝脏酶,在pH 7.0时,约0.2 microM的(6S)-5-CH(3)-H(4)PteGlu(5)浓度可导致半数最大抑制,而在pH 9.0时,该值增加至约1 microM。对于肝脏形式的该酶,在pH 7.4时,对S-腺苷甲硫氨酸的50%抑制作用发生在约0.27 microM处。从pH 7.4时的结合数据获得的解离常数K(s)为0.095。在pH 7.0时,每个四聚体结合约1摩尔的(6S)-5-CH(3)-H(4)PteGlu(5),在pH 9.0时结合1.6摩尔。在每个pH值下,结合程度和抑制程度密切平行。在(6R,6S)-和(6S)-5-CH(3)-H(4)PteGlu(5)浓度相等时,天然的(6S)形式的抑制作用约为前者的两倍。这些研究表明,甘氨酸N-甲基转移酶是一种高度别构的酶,这与其作为肝脏和胰腺中甲基代谢调节剂的作用相一致。